Involvement of caspase-8 in chemotherapy-induced apoptosis of patient derived leukemia cell lines independent of the death receptor pathway and downstream from mitochondria

Apoptosis

Volumn 12, Issue 1, 2007, Pages 181-193

  De Vries, J F ^a   Wammes, L J ^a   Jedema, I ^a   Van Dreunen, L ^a   Nijmeijer, B A ^a   Heemskerk, M H M ^a   Willemze, R ^a   Falkenburg, J H F ^a   Barge, R M Y ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Apoptosis; Caspase 8; Death receptor pathway; Leukemia; Mitochondrial pathway; Retroviral constructs

Indexed keywords

CAMPTOTHECIN; CASPASE 8; DAUNORUBICIN; DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; BONE MARROW CELL; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RESISTANCE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CAMPTOTHECIN; CASPASE 8; CASPASE 9; CELL LINE, TUMOR; DAUNORUBICIN; ENZYME ACTIVATION; HUMANS; LEUKEMIA; MITOCHONDRIA; RECEPTORS, DEATH DOMAIN;

EID: 33845728875     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-006-0526-6     Document Type: Article

References (41)

1. Zittoun RA, Mandelli F, Willemze R et al (1995) Autologous or allogeneic bone-marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med 332:217-223
2. Lowenberg B, Downing JR, Burnett A (1999) Medical progress - acute myeloid leukemia. N Engl J Med 341:1051-1062
3. Pui CH, Evans WE (1998) Acute lymphoblastic leukemia. N Engl J Med 339:605-615
4. Chauncey TR (2001) Drug resistance mechanisms in acute leukemia. Curr Opin Oncol 13:21-26
5. List AF (1996) Role of multidrug resistance and its pharmacological modulation in acute myeloid leukemia. Leukemia 10:937-942
6. Maung ZT, Maclean FR, Reid MM et al (1994) The relationship between Bcl-2 expression and response to chemotherapy in acute-leukemia. Br J Haematol 88:105-109
7. Pirker R, Wallner J, Geissler K et al (1991) Mdr1 gene-expression and treatment outcome in acute myeloid-leukemia. J Natl Cancer Inst 83:708-712
8. Stoetzer OJ, Nussler V, Darsow M et al (1996) Association of bcl-2, bax, bcl-xL and inteuleukin-1 beta-converting enzyme expression with initial response to chemotherapy in acute myeloid leukemia. Leukemia 10:S18-S22
9. Schimmer AD, Pedersen IM, Kitada S et al (2003) Functional blocks in caspase activation pathways are common in leukemia and predict patient response to induction chemotherapy. Cancer Res 63:1242-1248
10. Thornberry NA, Lazebnik Y (1998) Caspases: Enemies within. Science 281:1312-1316
11. Li P, Nijhawan D, Budihardjo I et al (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91:479-489
12. Friesen C, Herr I, Krammer PH, Debatin KM (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells. Nat Med 2:574-577
13. Friesen C, Fulda S, Debatin KM (1997) Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells. Leukemia 11:1833-1841
14. Fulda S, Sieverts H, Friesen C, Herr I, Debatin KM (1997) The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res 57:3823-3829
15. Herr I, Wilhelm D, Bohler T, Angel P, Debatin KM (1997) Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. Embo J 16:6200-6208
16. Muller M, Strand S, Hug H et al (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53. J Clin Invest 99:403-413
17. Chen GQ, Goeddel DV (2002) TNF-R1 signaling: A beautiful pathway. Science 296:1634-1635
18. Fulda S, Meyer E, Friesen C, Susin SA, Kroemer G, Debatin KM (2001) Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 20:1063-1075
19. Nagata S (1999) Fas ligand-induced apoptosis. Annu Rev Genet 33:29-55
20. Tourneur U, Delluc S, Levy V et al (2004) Absence or low expression of Fas-associated protein with death domain in acute myeloid leukemia cells predicts resistance to chemotherapy and poor outcome. Cancer Res 64:8101-8108
21. Kitada S, Pedersen IM, Schimmer AD, Reed JC (2002) Dysregulation of apoptosis genes in hematopoietic malignancies. Oncogene 21:3459-3474
22. Schimmer AD, Hedley DW, Penn LZ, Minden MD (2001) Receptor- and mitochondrial-mediated apoptosis in acute leukemia: A translational view. Blood 98:3541-3553
23. Chadderton A, Villeneuve DJ, Gluck S et al (2000) Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells. Breast Cancer Res Treat 59:231-244
24. Grotzer MA, Eggert A, Zuzak TJ et al (2000) Resistance to TRAIL-induced apoptosis in primitive neuroectodermal brain tumor cells correlates with a loss of caspase-8 expression. Oncogene 19:4604-4610
25. Teitz T, Wei T, Valentine MB et al (2000) Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med 6:529-535
26. Wesselborg S, Engels IH, Rossmann E, Los M, Schulze-Osthoff K (1999) Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93:3053-3063
27. Irmler M, Thome M, Hahne M et al (1997) Inhibition of death receptor signals by cellular FLIP. Nature 388:190-195
28. Thome M, Schneider P, Hofmann K et al (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521
29. Kluck RM, Bossy Wetzel E, Green DR, Newmeyer DD (1997) The release of cytochrome c from mitochondria: A primary site for Bcl-2 regulation of apoptosis. Science 275:1132-1136
30. Yang J, Liu XS, Bhalla K et al (1997) Prevention of apoptosis by Bcl-2: Release of cytochrome c from mitochondria blocked. Science 275:1129-1132
31. Lange B, Valtieri M, Santoli D et al (1987) Growth-Factor Requirements of Childhood Acute-Leukemia - Establishment of Gm-Csf Dependent Cell-Lines. Blood 70:192-199
32. Jedema I, Barge RM, Willemze R, Falkenburg JH (2003) High susceptibility of human leukemic cells to Fas-induced apoptosis is restricted to G1 phase of the cell cycle and can be increased by interferon treatment. Leukemia 17:576-584
33. Jedema I, Van Der Werff NM, Barge RM, Willemze R, Falkenburg JH (2004) New CFSE-based assay to determine susceptibility to lysis by cytotoxic T cells of leukemic precursor cells within a heterogeneous target cell population. Blood 103:2677-2682
34. Veuger MJT, Honders MW, Willemze R, Barge RMY (2002) Deoxycytidine kinase expression and activity in patientswith resistant versus sensitive acute myeloid leukemia. Eur J Haematol 69:171-178
35. Kinsella TM, Nolan GP (1996) Episomal vectors rapidly and stably produce high-titer recombinant retrovirus. Hum Gene Ther 7:1405-1413
36. Heemskerk MHM, de Paus RA, Lurvink EGA et al (2001) Dual HLA class I and class II restricted recognition of alloreactive T lymphocytes mediated by a single T cell receptor complex. Proc Natl Acad Sci USA 98:6806-6811
37. Hanenberg H, Xiao XL, Dilloo D, Hashino K, Kato I, Williams DA (1996) Colocalization of retrovirus and target cells on specific fibronectin fragments increases genetic transduction of mammalian cells. Nat Med 2:876-882
38. Rehemtulla A, Hamilton CA, Chinnaiyan AM, Dixit VM (1997) Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1). J Biol Chem 272:25783-25786
39. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT (1999) Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem 274:7987-7992
40. Chinnaiyan AM, ORourke K, Lane BR, Dixit VM (1997) Interaction of CED-4 with CED-3 and CED-9: A molecular framework for cell death. Science 275:1122-1126
41. Kim PKM, Mahidhara R, Seol DW (2001) The role of caspase-8 in resistance to cancer chemotherapy. Drug Resist Updates 4:293-296